Isosceles Pharmaceuticals
About:
Isosceles Pharmaceuticals is a preclinical stage biotech company that is working on perioperative acute pain product candidates.
Website: https://isoscelespharma.com/
Top Investors: Equifund
Description:
Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.
Total Funding Amount:
$5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Wilmington, North Carolina, United States
Founded Date:
2019-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2022-10-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai